SEC Form 4 · accession 0001013606-16-000334
ENDOLOGIX INC /DE/ · ELGX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
John D McDermott
Officer — Chief Executive Officer · Director
Period of report
Dec 14, 2016
Accepted (ET)
Dec 15, 2016 · 4:54 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001013606
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Dec 14, 2016 | P | 100 | $6.63 | A | 657,608 | D | |
| Common Stock | Dec 14, 2016 | P | 1,600 | $6.64 | A | 659,208 | D | |
| Common Stock | Dec 14, 2016 | P | 2,500 | $6.65 | A | 661,708 | D | |
| Common Stock | Dec 14, 2016 | P | 400 | $6.66 | A | 662,108 | D | |
| Common Stock | Dec 14, 2016 | P | 1,800 | $6.67 | A | 663,908 | D | |
| Common Stock | Dec 14, 2016 | P | 2,600 | $6.68 | A | 666,508 | D | |
| Common Stock | Dec 14, 2016 | P | 1,000 | $6.76 | A | 667,508 | D |
Table II — derivative securities
No Table II lines on this filing.